Telix Pharmaceuticals Ltd has released a press release.
Zircon P3 IND submitted to US FDA
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix and Vic Cancer Centre receive Cancer Australia grant
- Telix and ATONCO Partner for Bladder Cancer
- Telix and AusHealth Partner for Lung, Ovarian Cancer
- Appendix 4C - September 2019 quarter
- Telix to Acquire European Production Facility
Later from Telix Pharmaceuticals
- NDA Clinical Briefing Package Submitted to the US FDA
- Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging
- Appendix 4C - December 2019 Quarter
- Appendix 4E - Summary of Results
- Positive FDA feedback on NDA submission process
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals